BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36456424)

  • 1. The incorporation of next-generation sequencing into pediatric care.
    Lee NC
    Pediatr Neonatol; 2023 Feb; 64 Suppl 1():S30-S34. PubMed ID: 36456424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of genetic disorders in childhood with next-generation sequencing].
    Menyhárt O; Győrffy B; Szabó A
    Orv Hetil; 2022 Dec; 163(51):2027-2040. PubMed ID: 36528826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid genome sequencing for pediatrics.
    Jezkova J; Shaw S; Taverner NV; Williams HJ
    Hum Mutat; 2022 Nov; 43(11):1507-1518. PubMed ID: 36086948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
    Hong S; Wang L; Zhao D; Zhang Y; Chen Y; Tan J; Liang L; Zhu T
    Mol Genet Genomic Med; 2019 Jun; 7(6):e684. PubMed ID: 30968598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epilepsy syndromes, etiologies, and the use of next-generation sequencing in epilepsy presenting in the first 2 years of life: A population-based study.
    Stödberg T; Tomson T; Barbaro M; Stranneheim H; Anderlid BM; Carlsson S; Åmark P; Wedell A
    Epilepsia; 2020 Nov; 61(11):2486-2499. PubMed ID: 32964447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies.
    Grether A; Ivanovski I; Russo M; Begemann A; Steindl K; Abela L; Papik M; Zweier M; Oneda B; Joset P; Rauch A
    Mol Genet Genomic Med; 2023 May; 11(5):e2148. PubMed ID: 36785910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.
    Lelieveld SH; Spielmann M; Mundlos S; Veltman JA; Gilissen C
    Hum Mutat; 2015 Aug; 36(8):815-22. PubMed ID: 25973577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
    Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
    Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for whole genome sequencing in diagnostics for rare diseases.
    Souche E; Beltran S; Brosens E; Belmont JW; Fossum M; Riess O; Gilissen C; Ardeshirdavani A; Houge G; van Gijn M; Clayton-Smith J; Synofzik M; de Leeuw N; Deans ZC; Dincer Y; Eck SH; van der Crabben S; Balasubramanian M; Graessner H; Sturm M; Firth H; Ferlini A; Nabbout R; De Baere E; Liehr T; Macek M; Matthijs G; Scheffer H; Bauer P; Yntema HG; Weiss MM
    Eur J Hum Genet; 2022 Sep; 30(9):1017-1021. PubMed ID: 35577938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical points for an accurate human genome analysis.
    White SJ; Laros JFJ; Bakker E; Cambon-Thomsen A; Eden M; Leonard S; Lochmüller H; Matthijs G; Mattocks C; Patton S; Payne K; Scheffer H; Souche E; Thomassen E; Thompson R; Traeger-Synodinos J; Van Vooren S; Janssen B; den Dunnen JT
    Hum Mutat; 2017 Aug; 38(8):912-921. PubMed ID: 28471515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation diagnostics: gene panel, exome, or whole genome?
    Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
    Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
    Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
    Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.
    Soden SE; Saunders CJ; Willig LK; Farrow EG; Smith LD; Petrikin JE; LePichon JB; Miller NA; Thiffault I; Dinwiddie DL; Twist G; Noll A; Heese BA; Zellmer L; Atherton AM; Abdelmoity AT; Safina N; Nyp SS; Zuccarelli B; Larson IA; Modrcin A; Herd S; Creed M; Ye Z; Yuan X; Brodsky RA; Kingsmore SF
    Sci Transl Med; 2014 Dec; 6(265):265ra168. PubMed ID: 25473036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
    Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
    Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?
    Zawati MH; Parry D; Thorogood A; Nguyen MT; Boycott KM; Rosenblatt D; Knoppers BM
    J Med Genet; 2014 Jan; 51(1):68-70. PubMed ID: 24078715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
    Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
    J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.